SCHEMBL8669239

SCHEMBL8669239

Clc1nccc2c1ncn2Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 3/20 0.59
▸ EGLN1 Q9GZT9 1/20 0.59
▸ CYP11B1 P15538 3/20 0.54
▸ CYP11B2 P19099 3/20 0.54
▸ TNF P01375 1/20 0.54
▸ LMNA P02545 1/20 0.49
▸ EGLN3 Q9H6Z9 1/20 0.48
▸ YTHDC1 Q96MU7 1/20 0.48
▸ KDM4C Q9H3R0 1/20 0.47
▸ ADORA2A P29274 1/20 0.47
▸ PI4KA P42356 1/20 0.47
▸ PI4K2B Q8TCG2 1/20 0.47
▸ PI4K2A Q9BTU6 1/20 0.47
▸ PI4KB Q9UBF8 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ CDK1 P06493 1/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27244169 0.81 L3MBTL1 (0.56) CYP11B2LMNAADORA2ASMN1; SMN2MEN1
SCHEMBL22533661 0.81 EGLN1 (0.44) HTR6EGLN1CYP11B1CYP11B2EGLN3
SCHEMBL30881405 0.81 L3MBTL1 (0.56) CYP11B2LMNAADORA2ASMN1; SMN2MEN1
SCHEMBL29424873 0.81 EGLN1 (0.44) HTR6EGLN1CYP11B1CYP11B2EGLN3
SCHEMBL3449511 0.78 RPS6KA5 (0.41) HTR6EGLN1LMNAYTHDC1ADORA2A
SCHEMBL16331917 0.78 HTR6 (0.53) HTR6EGLN1CYP11B1CYP11B2TNF
SCHEMBL23531695 0.76 EGLN1 (0.48) EGLN1LMNAEGLN3ALDH1A1POLB
SCHEMBL23531669 0.76 EGLN1 (0.38) HTR6EGLN1CYP11B1CYP11B2LMNA
SCHEMBL3788877 0.74 CYP11B1 (0.58) HTR6EGLN1CYP11B1CYP11B2TNF
SCHEMBL4566468 0.74 CYP11B1 (0.58) HTR6EGLN1CYP11B1CYP11B2TNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399302-A1 PROCESS FOR THE PREPARATION OF HETEROARYL-SUBSTITUTED SULFUR(VI) COMPOUNDS NATIONAL INSTITUTES OF HEALTH 2023-12-14 — — US disclosed
US-5723468-A COGNITION ACTIVATORS FOR MEMOY LOSS AMERICAN HOME PRODUCTS CORPORATION (US) 1998-03-03 — — US disclosed
US-5571819-A Imidazopyridines as muscarinic agents WYETH 1996-11-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399302-A1 PROCESS FOR THE PREPARATION OF HETEROARYL-SUBSTITUTED SULFUR(VI) COMPOUNDS TST, TYR, STS HTR6 747/4885EGLN1 4709/4885CYP11B1 661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback